Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease
Open Access
- 7 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (8) , 2635-2641
Abstract
Background. The diagnosis of uraemic encephalopathy is considered if patients with end-stage renal disease present with neuropsychiatric symptoms. However, cognitive deficits may occur in patients with chronic kidney disease (CKD) long before any overt neurological symptoms can be observed. We hypothesized that cognitive dysfunction in patients with CKD both, treated and untreated by haemodialysis, may correspond to metabolic changes in distinct brain regions. Methods. We performed magnetic resonance spectroscopy (MRS) ( 1 H-MRS) of the brain in 23 non-dialysed patients with CKD (Stages 4–5) and in 15 haemodialysed patients. Healthy controls ( n = 63) adjusted for age and education were recruited from the social environment of the patients' population. Attention, learning and memory were assessed by psychometric testing. Results. MRS alterations were predominantly found in the white matter. Concentrations of creatine-containing compounds (Cr) were decreased in dialysed and non-dialysed patients. Choline concentration (Cho) and combined N -acetylaspartate and N -acetylaspartylglutamate concentration (NAx) were reduced only in dialysed patients. Disturbance in memory and learning ability as well as attention deficits were observed in both patient groups. Of note, attention deficits were more severe in dialysed patients. MRS results correlated with attention deficits in dialysed patients. Conclusions. CKD patients without clinical signs of uraemic encephalopathy showed metabolic disturbances in distinct brain regions as well as cognitive impairments. Haemodialysis was accompanied with more severe cognitive dysfunction and metabolic alternations than CKD alone. Although the small sample size limits the interpretation of the data, a negative impact of haemodialysis on cognitive function must be considered.Keywords
This publication has 31 references indexed in Scilit:
- Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) StudyAmerican Journal of Kidney Diseases, 2008
- N -Acetylaspartate and N -acetylaspartylglutamateNeurology, 2008
- Long and short echo time proton magnetic resonance spectroscopic imaging of the healthy aging brainJournal of Magnetic Resonance Imaging, 2007
- Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathyGut, 2007
- Moderate Chronic Kidney Disease and Cognitive Function in Adults 20 to 59 Years of AgeJournal of the American Society of Nephrology, 2007
- Neurological complications in renal failure: a reviewClinical Neurology and Neurosurgery, 2004
- Endogenous guanidino compounds as uremic neurotoxinsKidney International, 2001
- Dialysis and transplantation affect cerebral abnormalities of end‐stage renal diseaseJournal of Magnetic Resonance Imaging, 1996
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- Proton magnetic resonance spectroscopy in chronic renal failureThe Lancet, 1991